Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer

NCT00957086 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

710

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Squamous Cell of Head and Neck

Interventions

DRUG: Nimotuzumab
DRUG: Placebo

Sponsor

National Cancer Centre, Singapore

Collaborators

[object Object]
[object Object]